Prior to joining TMI, Pidcoke also served as chief medical officer of Cellphire Inc., a biotechnology company focused on developing freeze-dried blood ...
News
- CSU hires first chief medical research officer
- Houston drug maker targeting cancer tumors gains special FDA approval
Houston-based Moleculin Biotech Inc., a clinical stage pharmaceutical company, has gained fast-track U.S. Food and Drug Administration approval for ...
- San Antonio wound-care company files for initial public offering
San Antonio wound-care company Acelity, formerly known as Kinetic ... That year, the company completed the sale of LifeCell Corp., a biomedical ...
- EPS for Celcuity Inc. (CELC) Expected At $-0.22 on May, 13
... Studies at the 2018 San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with ... “Celcuity Announces Clinical Trial Collaboration with Puma Biotechnology and West Cancer Center – Business ...
- Anticipated $-0.22 EPS for Celcuity Inc. (CELC) on May, 13
... Stocks Year-to-Date – Investing News Network” published on December 04, 2018, “Biotech startup Celcuity raises ... San Antonio Breast Cancer Symposium Evaluating HER2-Negative Breast Cancer Tumors with Hyperactive and ...